Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease
Samantha Budd Haeberlein(Biogen (United States)), Alfred Sandrock(Biogen (United States))
Cited by 1,293
Related Papers
Natalizumab and Progressive Multifocal Leukoencephalopathy
|New England Journal of Medicine|2005|82
Regulation of Rat Pineal Hydroxyindole‐<i>O</i>‐Methyltransferase: Evidence of <i>S</i>‐Adenosylmethionine‐Mediated Glucocorticoid Control
|Journal of Neurochemistry|1980|19
Introduction
|Developmental Neuroscience|1989|0
Erratum
|Developmental Neuroscience|1989|0